Last reviewed · How we verify

NCT07197151

CYFIP1 and PKM2 Synergistically Regulate ROS and Glycolysis in Colorectal Cancer Through the AKT/mTOR/HIF-1α Cascad

Completed Last updated 29 September 2025
What this trial tests

trial testing Perform surgery on patients with colorectal cancer and collect cancer and adjacent tissue specimens in Colorectal Cancer (CRC) in 32 participants. Completed in 1 September 2025.

Timeline
1 August 2022
Primary endpoint
1 September 2025
1 September 2025

Quick facts

Lead sponsorhui hou
StatusCompleted
Study typeOBSERVATIONAL
Enrollment32
Start date1 August 2022
Primary completion1 September 2025
Estimated completion1 September 2025
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

hui hou

Who can join

Eligibility, any sex, with Colorectal Cancer (CRC) or Specimens Are to be Collected From Subjects Who Are Having or Have Had a Fluid or Tissue Removed, a Biopsy or a Blood or Bone Marrow Draw. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Collect some tumor tissue specimens from patients who have undergone colorectal cancer surgery and conduct experiments such as immunohistochemistry to observe the expression of related genes in colorectal cancer.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Targeting Glycolytic Metabolism in Cancer Therapy: Current Approaches and Future Perspectives.
    Li S, Gong J, Kang B, Wang Z, et al · · 2026 · PMID 41744805 · DOI 10.3390/cells15040362

Verify or expand the search:

Other recruiting trials for Colorectal Cancer (CRC)

Currently open trials in the same condition.

Other hui hou trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07197151.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing